ESR1 and cancer: Indeed, MD simulation studies on the interactionsof the two compounds with the ERα LBD support this hypothesis.The two metallodrugs were also able to induce a redox imbalance inbreast cancer cells (both ER+ and ER–), as shown by an increased ROS production and reduction of thiolgroups.